Avalo Therapeutics (AVTX) Prepaid Assets (2014 - 2026)
Avalo Therapeutics (AVTX) posted Prepaid Assets of $6.7 million for Q1 2026, down 3.3% on a QoQ basis from $6.9 million in Q4 2025, and up 264.7% year-over-year from $1.8 million in Q1 2025.
Avalo Therapeutics (AVTX) Prepaid Assets (2014 - 2026) Analysis & Trends
Avalo Therapeutics' Prepaid Assets history runs 13 years deep, the most recent figure standing at $6.7 million for Q1 2026.
- Quarterly Prepaid Assets rose 264.7% year-over-year to $6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (up 264.7% YoY) and the FY2025 annual result came in at $6.9 million, up 59.84% from the prior year.
- Prepaid Assets was $6.7 million for Q1 2026 at Avalo Therapeutics, down from $6.9 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $6.9 million in Q4 2025 and bottomed at $100000.0 in Q1 2024.
- A 5-year average of $2.1 million and a median of $1.6 million in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets tumbled 93.85% — and 2025, when it soared 1803.0%.
- Avalo Therapeutics' Prepaid Assets stood at $1.3 million in 2022, then plunged by 61.24% to $500000.0 in 2023, then surged by 765.0% to $4.3 million in 2024, then soared by 59.84% to $6.9 million in 2025, then dropped by 3.3% to $6.7 million in 2026.
- Business Quant data shows AVTX's Prepaid Assets at $6.7 million in Q1 2026, $6.9 million in Q4 2025, and $2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.69 Mn |
| Dec 31, 2025 | 6.91 Mn |
| Sep 30, 2025 | 2.14 Mn |
| Jun 30, 2025 | 1.90 Mn |
| Mar 31, 2025 | 1.83 Mn |
| Dec 31, 2024 | 4.33 Mn |
| Sep 30, 2024 | 900,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Sep 30, 2023 | 940,000.00 |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | 1.63 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 1.12 Mn |
| Jun 30, 2022 | 1.89 Mn |
| Mar 31, 2022 | 2.68 Mn |
| Dec 31, 2021 | 2.37 Mn |
| Sep 30, 2021 | 1.41 Mn |
| Jun 30, 2021 | 1.75 Mn |